Synageva BioPharma

Synageva BioPharma

Verified
Discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$8.4b (Public information from May 2015)
Middlesex County Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
N/AN/ASeries B
$13.1mSeries D
$10.1mSeries E
$17.2mSeries E
$30mSeries F
$12mSeries F
N/A$3mSeries F
$25mLate VC
N/AN/AIPO
*
N/A$179mPost IPO Equity
Not yet verified
*
N/A$308mPost IPO Equity
Not yet verified
$8.4b
Valuation: $8.4b
Acquisition
Total Funding$110m

Recent News about Synageva BioPharma

Edit